SLC26A4 and cardiac hypertrophy: We showed that siRNA-SLC26A4 treatment could promote apoptosis of cardiomyocytes induced by PE, indicating that inhibiting SLC26A4 could remodel cardiac structure after cardiac hypertrophy through the induction of apoptosis.